Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04224493 |
|---|---|
| Brief Title: | Study of Tazemetostat Versus Placebo When Given in Combination With Lenalidomide and Rituximab in Participants With Relapsed/Refractory Follicular Lymphoma (SYMPHONY-1) |
| First Submitted : | December 12, 2019 |
| First Submitted that Met QC Criteria : | January 8, 2020 |
| First Posted : | January 13, 2020 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 8, 2024 (Estimate) |